AU2001292864A1 - Methods and compositions for modulating angiogenesis - Google Patents

Methods and compositions for modulating angiogenesis

Info

Publication number
AU2001292864A1
AU2001292864A1 AU2001292864A AU9286401A AU2001292864A1 AU 2001292864 A1 AU2001292864 A1 AU 2001292864A1 AU 2001292864 A AU2001292864 A AU 2001292864A AU 9286401 A AU9286401 A AU 9286401A AU 2001292864 A1 AU2001292864 A1 AU 2001292864A1
Authority
AU
Australia
Prior art keywords
compositions
methods
modulating angiogenesis
angiogenesis
modulating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001292864A
Inventor
Feng Chen
Gerald R Crabtree
Isabella Graef
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of AU2001292864A1 publication Critical patent/AU2001292864A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Mechanical Light Control Or Optical Switches (AREA)
AU2001292864A 2000-09-21 2001-09-19 Methods and compositions for modulating angiogenesis Abandoned AU2001292864A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23469400P 2000-09-21 2000-09-21
US60234694 2000-09-21
PCT/US2001/029436 WO2002024957A1 (en) 2000-09-21 2001-09-19 Methods and compositions for modulating angiogenesis

Publications (1)

Publication Number Publication Date
AU2001292864A1 true AU2001292864A1 (en) 2002-04-02

Family

ID=22882413

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001292864A Abandoned AU2001292864A1 (en) 2000-09-21 2001-09-19 Methods and compositions for modulating angiogenesis

Country Status (3)

Country Link
US (2) US6687428B2 (en)
AU (1) AU2001292864A1 (en)
WO (1) WO2002024957A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6633694B2 (en) * 2000-09-29 2003-10-14 Texas Instruments Incorporated Micromirror optical switch
US7039267B2 (en) * 2000-11-20 2006-05-02 Jds Uniphase Inc. Optical switch
US20020154354A1 (en) * 2001-04-20 2002-10-24 Kannan Raj Optically interconnecting multiple processors
CA2394936C (en) * 2001-07-25 2011-12-13 Jds Uniphase Inc. Wavelength cross-connect
US20040207893A1 (en) * 2002-03-14 2004-10-21 Miller Samuel Lee Channel processing unit for WDM network
FR2849055A1 (en) * 2002-12-18 2004-06-25 Exonhit Therapeutics Sa Using inhibitors of protein FKBP65 for treating cancer and other diseases where angiogenesis is involved, also new isoforms of FKBP65, related nucleic acids and diagnostic uses
US20050014680A1 (en) * 2003-04-15 2005-01-20 Crabtree Gerald R. Methods and compositions for enhancing neuron growth and survival
US7154587B2 (en) * 2003-06-30 2006-12-26 Asml Netherlands B.V Spatial light modulator, lithographic apparatus and device manufacturing method
FR2864258B1 (en) * 2003-12-23 2006-02-17 Commissariat Energie Atomique SIMPLIFIED OPTIC SWITCH
US7099528B2 (en) * 2004-01-07 2006-08-29 International Business Machines Corporation Methods and devices for coupling electromagnetic radiation using diffractive optical elements
US8045002B2 (en) * 2005-07-29 2011-10-25 Mitutoyo Corporation Systems and methods for controlling strobe illumination
US9234852B2 (en) 2005-07-29 2016-01-12 Mitutoyo Corporation Systems and methods for controlling strobe illumination
EP1787645A1 (en) * 2005-11-18 2007-05-23 Institut Curie New method for treating cancer based on the modulation of the calcineurin and/or the calcineurin/NFAT pathway
US20070188443A1 (en) * 2006-02-14 2007-08-16 Texas Instruments Incorporated System and method for displaying images
GB0719180D0 (en) 2007-10-02 2007-11-14 Cambrex Karlskoga Ab New process
JP2011523551A (en) * 2008-05-15 2011-08-18 ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル A novel target for the regulation of angiogenesis
CN102382796B (en) * 2010-08-31 2014-08-27 中国科学院上海生命科学研究院 Method and reagent for regulation and control of germ layer differentiation of embryonic stem cell and early embryo
KR101683635B1 (en) 2014-12-29 2016-12-09 가천대학교 산학협력단 Pharmaceutical composition for treating cancer comprising lactate metallic salts
MX2020007462A (en) 2018-01-12 2020-09-14 Metimedi Pharmaceuticals Co Ltd Methods of treating chronic inflammatory diseases.
GB202206310D0 (en) * 2022-04-29 2022-06-15 Huber Suhner Polatis Ltd Optical steering utilising optical beam steering

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935931A (en) 1989-02-28 1990-06-19 University Of New Mexico Laser mode locking apparatus
US4933944A (en) 1989-02-28 1990-06-12 University Of New Mexico Laser mode locking method and apparatus
US5177633A (en) 1989-10-12 1993-01-05 Massachusetts Institute Of Technology Optical parametric oscillator wideband frequency comb generator
US5070260A (en) 1989-10-12 1991-12-03 Massachusetts Institute Of Technology Ultrahigh-resolution optical parametric oscillator frequency measurement and synthesis system
WO1993004203A1 (en) * 1991-08-22 1993-03-04 The Board Of Trustees Of The Leland Stanford Jr. University Screening methods for immunosuppressive agents
US6197925B1 (en) 1991-08-22 2001-03-06 Sara Lee Corporation NF-AT polypeptides and polynucleotides
JP2928046B2 (en) 1993-04-16 1999-07-28 日本電気株式会社 Optical network and its fault recovery system
US5408556A (en) 1993-12-06 1995-04-18 Kaptron, Inc. 1 X N splitter for single-mode fibers and method of construction
US5907425A (en) 1995-12-19 1999-05-25 The Board Of Trustees Of The Leland Stanford Junior University Miniature scanning confocal microscope
US5867291A (en) 1996-10-29 1999-02-02 Chorum Technologies Inc. Programmable wavelength router
US5872880A (en) 1996-08-12 1999-02-16 Ronald S. Maynard Hybrid-optical multi-axis beam steering apparatus
US5715337A (en) 1996-09-19 1998-02-03 The Mirco Optical Corporation Compact display system
US5937117A (en) 1996-12-27 1999-08-10 Nippon Telegraph And Telephone Corporation Optical cross-connect system
US6097859A (en) 1998-02-12 2000-08-01 The Regents Of The University Of California Multi-wavelength cross-connect optical switch
US6154587A (en) 1997-03-21 2000-11-28 Oki Electric Industry Co., Ltd. Optical cross connector apparatus
US6075239A (en) 1997-09-10 2000-06-13 Lucent Technologies, Inc. Article comprising a light-actuated micromechanical photonic switch
US6038058A (en) 1998-10-15 2000-03-14 Memsolutions, Inc. Grid-actuated charge controlled mirror and method of addressing the same
JP3552601B2 (en) 1998-11-16 2004-08-11 日本ビクター株式会社 Optical deflector and display device using the same
US6205267B1 (en) 1998-11-20 2001-03-20 Lucent Technologies Optical switch
WO2000030671A2 (en) 1998-11-24 2000-06-02 The Board Of Trustees Of The Leland Stanford Jr. University Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
JP3705710B2 (en) 1998-12-08 2005-10-12 沖電気工業株式会社 Optical cross-connect device and switching device
US6229640B1 (en) 1999-08-11 2001-05-08 Adc Telecommunications, Inc. Microelectromechanical optical switch and method of manufacture thereof
US6222954B1 (en) 1999-09-17 2001-04-24 Light Bytes, Inc. Fault-tolerant fiber-optical beam control modules
US6259835B1 (en) 1999-10-12 2001-07-10 Primawave Photonics, Inc. Mechanically actuated optical switch
US6587611B1 (en) * 2000-06-06 2003-07-01 Calient Networks, Inc. Maintaining path integrity in an optical switch
US6430328B1 (en) * 2000-10-13 2002-08-06 William H. Culver Optical switch

Also Published As

Publication number Publication date
US20020067880A1 (en) 2002-06-06
US6687428B2 (en) 2004-02-03
US20020042360A1 (en) 2002-04-11
US7323439B2 (en) 2008-01-29
WO2002024957A1 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2001282877A1 (en) Cosmetic compositions
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2001292864A1 (en) Methods and compositions for modulating angiogenesis
AU2002246666A1 (en) Anti-icing composition
AU2001219651A1 (en) Mulch composition and method
AU2001293189A1 (en) Compositions and methods for regulating apoptosis
AU2001253179A1 (en) Defoamer compositions and uses therefor
AU2001265919A1 (en) Cosmetic compositions
AU2001283845A1 (en) Flavour composition
AU2001293728A1 (en) Cosmetic composition
AUPQ875700A0 (en) Combination compositions
AU2002236626A1 (en) Compositions and methods for treating hyperpigmentation
AU2001241098A1 (en) Composition
AU2001233932A1 (en) Method and composition
AU2001280588A1 (en) Methods of modulating angiogenesis
AU2001275201A1 (en) Acne-treating composition
AU6720100A (en) Depigmenting compositions
AU2001233086A1 (en) Ceramidase compositions and methods based thereon
AUPR204000A0 (en) Femoral haemostasis device
AU2001287852A1 (en) Composition
AU2001256202A1 (en) Cosmetic compositions
AU2001235764A1 (en) Compositions
AU2002239775A1 (en) Chemical-library composition and method
AU2001267541A1 (en) Vaccine composition